Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis

Journal of Oral Pathology and Medicine

Volumn 39, Issue 6, 2010, Pages 470-476

  Zhang, Lei ^a   Pan, Hong Ya ^a   Zhong, Lai Ping ^a   Wei, Kui Jie ^a   Yang, Xiao ^a   Li, Jiang ^a   Shen, Guo Fang ^a   Zhang, Zhiyuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

fos related activator 1; immunohistochemistry; oral squamous cell carcinoma; quantitative real time RT PCR

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR FRA 1; PROTEIN C FOS; RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; PATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; ENZYME IMMUNOASSAY; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MOUTH TUMOR; NONPARAMETRIC TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSFORMED CELL LINE; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-FOS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77954366351     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00869.x     Document Type: Article

References (39)

1. Kademani D. Oral cancer. Mayo Clin Proc 2007 82 : 878 887.
2. Petersen PE. The World Oral Health Report 2003: continuous improvement of oral health in the 21st century-the approach of WHO Global Oral Programme. Community Dent Oral Epidemiol 2003 31 (Suppl. 3 23.
3. Sdek P, Zhang ZY, Cao J, Pan HY, Chen WT, Zheng JW. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. Int J Oral Maxillofac Surg 2006 35 : 653 657.
4. Zhong LP, Pan HY, Zhou XJ, et al. Characteristics of a cancerous cell line, HIOEC-B(a)P-96, induced by benzo(a)pyrene from human immortalized oral epithelial cell line. Arch Oral Biol 2008 53 : 443 452.
5. Adiseshaiah P, Peddakama S, Zhang Q, Kalvakolanu DV, Reddy SP. Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements. Oncogene 2005 24 : 4193 4205.
6. Jochum W, Passegue E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene 2001 20 : 2401 2412.
7. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002 4 : 131 136.
8. Curran T, Franza BR Jr. Fos and Jun: the AP-1 connection. Cell 1988 55 : 395 397.
9. Rauscher FJ III., Cohen DR, Curran T, et al. Fos-associated protein p39 is the product of the jun proto-oncogene. Science 1988 240 : 1010 1016.
10. Wagner EF. AP-1 - Introductory remarks. Oncogene 2001 20 : 2334 2335.
11. Suzuki T, Murakami M, Onai N, et al. Analysis of AP-1 function in cellular transformation pathways. J Virol 1994 68 : 3527 3535.
12. Kustikova O, Kramerov D, Grigorian M, et al. Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol 1998 118 : 7095 7105.
13. Vallone D, Battista S, Pierantoni GM, et al. Neoplastic trasformation of rat thyroid cells requires the fra-1 gene induction and multiple regulatory changes of the AP-1 components: role of the HMGI-C protein. EMBO J 1997 16 : 5310 5321.
14. Ramos-Nino ME, Timblin CR, Mossman BT. Mesothelial cell transformation requires increased AP-1 binding activity and ERK dependent Fra-1 expression. Cancer Res 2002 62 : 6065 6069.
15. Mechta F, Lallemand D, Pfarr CM, Yaniv M. Transformation by ras modifies AP1 composition and activity. Oncogene 1997 14 : 837 847.
16. Belguise K, Kersual N, Galtier F, Chalbos D. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 2005 17 : 1434 1444.
17. Young MR, Yang HS, Colburn NH. Promising molecular targets for cancer prevention: AP-1, NF-kappaB and Pdcd4. Trends Mol Med 2003 9 : 36 41.
18. Battista S, de Nigris F, Fedele M, et al. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. Oncogene 1998 17 : 377 385.
19. Fung LF, Lo AK, Yuen PW, Liu Y, Wang XH, Tsao SW. Differential gene expression in nasopharyngeal carcinoma cells. Life Sci 2000 67 : 923 936.
20. Tarbe N, Losch S, Burtscher H, Jarsch M, Weidle UH. Identification of rat pancreatic carcinoma genes associated with lymphogenous metastasis. Anticancer Res 2002 22 : 2015 2027.
21. Ramos-Nino ME, Scapoli L, Martinelli M, Land S, Mossmann BT. Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma. Cancer Res 2003 63 : 3539 3545.
22. Zhong LP, Chen WT, Zhan CP, Zhang ZY. Increased CK19 expression correlated with pathological differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 104 : 377 384.
23. Zhong LP, Zhang CP, Li J, Chen WT, Zhang ZY. Increase of Cyfra 21-1 concentration in saliva from oral squamous cell carcinoma patients. Arch Oral Biol 2007 52 : 1079 1087.
24. Sobin LH, Wittekind CH, eds. International Union Against Cancer (UICC). TNM classification of malignant tumours, 6th edn.
25. -δδCt method. Methods 2001 25 : 402 408.
26. Zhang W, Hart J, McLeod HL, Wang HL. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms. Am J Clin Pathol 2005 124 : 11 9.
27. Califano J, Van P, Westra W, Nawroz H, Clayman G, Piantadosi S. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996 56 : 2488 2492.
28. Li JZ, Pan HY, Zheng JW, et al. Benzo (a) pyrene induced tumorigenesity of human immortalized oral epithelial cells: transcription profiling. Chin Med J 2008 121 : 1882 1890.
29. Pollock CB, Shirasawa S, Sasazuki T, Kolch W, Dhillon AS. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. Cancer Res 2005 65 : 1244 1250.
30. Zerbini LF, Wang Y, Cho JY, Libermann TA. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Res 2003 63 : 2206 2215.
31. Debinski W, Gibo DM. Fos-related antigen 1 modulates malignant features of glioma cells. Mol Cancer Res 2005 3 : 237 249.
32. Kim YH, Oh JH, Kim NH, et al. Fra-1 expression in malignant and benign thyroid tumor. Korean J Intern Med 2001 16 : 93 7.
33. Chiappetta G, Ferraro A, Botti G, et al. FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. BMC Cancer 2007 7 : 17 27.
34. Chrysovalantis A, Margarita K, Angeliki V, Alexander P. Fra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cells. Int J Cancer 2008 122 : 1745 1756.
35. Ma K, Chang D, Gong M, et al. Expression and significance of FRA-1 in non-small-cell lung cancer. Cancer Invest 2009 27 : 353 359.
36. Burch PM, Yuan Z, Loonen A, Heintz NH. An extracellular signalregulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry. Mol Cell Biol 2004 24 : 4696 4709.
37. Vial E, Sahai E, Marshall CJ. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cells 2003 4 : 67 79.
38. Darnell JE Jr. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002 2 : 740 749.
39. Young MR, Colburn NH. Fra-1 a target for cancer prevention or intervention. Gene 2006 379 : 1 11.